The Wall Street Journal @WSJ
Breaking: The FDA has delayed a decision on clearing Moderna's Covid-19 vaccine for 12-to-17-year-olds while it looks into the risk of the rare heart condition myocarditis, people familiar with the matter say https://t.co/fIs0sypYzv — PolitiTweet.org